Scope Fluidics

Scope Fluidics S.A. is a biotechnology company located in Warsaw, Poland, that specializes in innovative medical diagnostic solutions using microfluidic technologies. Founded in 2010, the company focuses on developing faster, accessible, and cost-effective diagnostic systems, particularly for infectious disease diagnostics and antibiotic susceptibility testing. The company operates through special-purpose vehicles (SPVs) dedicated to specific diagnostic technologies. Key products include BacterOMIC, which assesses the drug susceptibility of microorganisms, and PCR|ONE, a rapid gene diagnostic device that uses real-time PCR technology to detect pathogens. These products are designed for use in hospitals, emergency departments, outpatient clinics, and point-of-care settings, aiming to improve treatment quality and address urgent healthcare needs. Scope Fluidics is publicly listed on the Warsaw Stock Exchange and employs around 63 people. The company emphasizes creativity and responsibility in delivering healthcare solutions and actively seeks collaborations to enhance the impact of its technologies.

• Employees 70
• Founded 2010
• Annual Revenue $31000
• Total Funding $12000000